- Home
- QNRX vs SNES Comparison
QNRX vs SNES Comparison
Compare QNRX & SNES Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- QNRX
- SNES
- Stock Information
- Founded
- QNRX 2018
- SNES 2004
- Country
- QNRX United States
- SNES United States
- Employees
- QNRX N/A
- SNES N/A
- Industry
- QNRX Medical/Dental Instruments
- SNES Agricultural Chemicals
- Sector
- QNRX Health Care
- SNES Industrials
- Exchange
- QNRX Nasdaq
- SNES Nasdaq
- Market Cap
- QNRX 2.5M
- SNES 2.3M
- IPO Year
- QNRX N/A
- SNES 2016
- Fundamental
- Price
- QNRX $0.24
- SNES $1.88
- Analyst Decision
- QNRX
- SNES Strong Buy
- Analyst Count
- QNRX 0
- SNES 1
- Target Price
- QNRX N/A
- SNES $10.00
- AVG Volume (30 Days)
- QNRX 567.3K
- SNES 231.1K
- Earning Date
- QNRX 03-13-2025
- SNES 03-12-2025
- Dividend Yield
- QNRX N/A
- SNES N/A
- EPS Growth
- QNRX N/A
- SNES N/A
- EPS
- QNRX N/A
- SNES N/A
- Revenue
- QNRX N/A
- SNES $1,857,000.00
- Revenue This Year
- QNRX N/A
- SNES $130.53
- Revenue Next Year
- QNRX N/A
- SNES $80.00
- P/E Ratio
- QNRX N/A
- SNES N/A
- Revenue Growth
- QNRX N/A
- SNES 55.66
- 52 Week Low
- QNRX $0.24
- SNES $1.88
- 52 Week High
- QNRX $1.57
- SNES $9.80
- Technical
- Relative Strength Index (RSI)
- QNRX 32.92
- SNES 32.08
- Support Level
- QNRX $0.28
- SNES $2.10
- Resistance Level
- QNRX $0.32
- SNES $2.34
- Average True Range (ATR)
- QNRX 0.02
- SNES 0.21
- MACD
- QNRX 0.00
- SNES -0.02
- Stochastic Oscillator
- QNRX 2.31
- SNES 0.00
About QNRX Quoin Pharmaceuticals Ltd.
Quoin Pharmaceuticals Ltd is a clinical stage specialty pharmaceutical company focused on developing and commercializing therapeutic products that treat rare and orphan diseases. Its pipeline comprises three products that collectively have the potential to target a broad number of rare and orphan indications, including Netherton Syndrome, Peeling Skin Syndrome, Palmoplantar Keratoderma, Epidermolysis Bullosa, and others.
About SNES SenesTech Inc.
SenesTech Inc is a United States-based biotech platform and research company engaged in developing technology for managing animal pest populations through fertility control. The company provides its solutions to the animal market, commercial markets, and food markets. It currently has two product lines of fertility control products: ContraPest and Evolve.